Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Debt to Equity (2016 - 2023)

Marimed (MRMD) has disclosed Debt to Equity for 12 consecutive years, with $0.28 as the latest value for Q3 2023.

  • On a quarterly basis, Debt to Equity changed N/A to $0.28 in Q3 2023 year-over-year; TTM through Sep 2023 was $0.28, a N/A change, with the full-year FY2021 number at $0.48, down 67.47% from a year prior.
  • Debt to Equity was $0.28 for Q3 2023 at Marimed, down from $0.3 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $153.66 in Q3 2020 to a low of -$2.84 in Q2 2020.
  • A 5-year average of $9.59 and a median of $0.15 in 2021 define the central range for Debt to Equity.
  • Biggest YoY gain for Debt to Equity was 3060128.43% in 2020; the steepest drop was 304992.6% in 2020.
  • Marimed's Debt to Equity stood at $0.28 in 2019, then surged by 427.16% to $1.46 in 2020, then crashed by 67.47% to $0.48 in 2021, then plummeted by 99.78% to $0.0 in 2022, then surged by 26589.78% to $0.28 in 2023.
  • Per Business Quant, the three most recent readings for MRMD's Debt to Equity are $0.28 (Q3 2023), $0.3 (Q2 2023), and $0.37 (Q1 2023).